鍏充簬鍗庢皬宸ㄧ悆铔嬬櫧琛€鐥�<\/b> <\/b><\/p> \n
鍗庢皬宸ㄧ悆铔嬬櫧琛€鐥囷紙WM锛夋槸涓€绉嶇綍瑙佹儼鎬缁嗚優娣嬪反鐦わ紝鍦ㄤ笉鍒�2%鐨勯潪闇嶅閲戞穻宸寸槫锛圢HL锛夋偅鑰呬腑鍑虹幇銆傝鐤剧梾閫氬父鍑虹幇鍦ㄥ勾闀挎偅鑰呬腑锛屼富瑕佸湪楠ㄩ珦涓彂鐜帮紝浣嗕篃鍙兘绱強娣嬪反缁撳拰鑴捐剰[ii]<\/sup><\/span>銆傚湪鍔犳嬁澶у拰缇庡浗锛學M鐨勫彂鐥呯巼绾︿负姣忓勾姣忕櫨涓囦汉涓簲渚�[iii]<\/span><\/sup>銆�<\/p> \n
鍏充簬<\/b>ASPEN<\/span><\/b>涓村簥璇曢獙<\/b> <\/b><\/p> \n
杩欓」闅忔満銆佸紑鏀俱€佸涓績鐨凙SPEN 3鏈熶复搴婅瘯楠岋紙clinicaltrials.gov 鐧昏鍙凤細 NCT03053440锛夌敤浜庤瘎浼扮櫨鎮︽辰®<\/sup>瀵规瘮浼婂竷鏇垮凹娌荤枟澶嶅彂\/闅炬不鎬э紙R\/R锛変互鍙婂垵娌� 锛圱N锛夊崕姘忓法鐞冭泲鐧借鐥囷紙WM锛夋偅鑰呫€傝瘯楠屼富瑕佺洰鐨勪负閫氳繃璇勪及瀹屽叏缂撹В锛圕R锛夋垨闈炲父濂界殑閮ㄥ垎缂撹В锛圴GPR锛変互纭瘉 鐧炬偊娉�®<\/sup>瀵规瘮浼婂竷鏇垮凹鍏锋湁浼樻晥鎬с€傝瘯楠屾瑕佺粓鐐瑰寘鎷富瑕佺紦瑙g巼銆佹寔缁紦瑙f椂闂翠互鍙婃棤杩涘睍鐢熷瓨鏈熴€佸畨鍏ㄦ€э紙鐢辨不鐤楁湡闂村嚭鐜扮殑涓嶈壇浜嬩欢鍙戠敓鐜囥€佹椂闂村拰涓ラ噸鎬ф潵鍐冲畾锛夈€傝璇曢獙棰勫厛纭畾鐨勫垎鏋愭偅鑰呬汉缇ゅ寘鎷墍鏈夋偅鑰咃紙n=201锛変互鍙� R\/R 鎮h€咃紙n=164锛夈€傝瘯楠屾帰绱㈡€х粓鐐瑰寘鎷敓娲昏川閲忚 閲忋€�<\/p> \n
璇ヨ瘯楠屽寘鎷袱涓槦鍒楋紝涓€涓槸闅忔満闃熷垪锛堥槦鍒�1锛夛紝鍏ョ粍浜�201鍚嶆惡甯� MYD88 鍩哄洜绐佸彉鐨勬偅鑰咃紝鍙︿竴涓槸闈為殢鏈洪槦鍒楋紙闃熷垪2锛夛紝鍏ョ粍浜�28渚嬫惡甯YD88閲庣敓鍩哄洜鍨嬶紙MYD88WT锛夋偅鑰咃紝閮芥帴鍙楁辰甯冩浛灏兼不鐤椼€傝繖绫绘偅鑰呭湪鍘嗗彶鐮旂┒涓帴鍙椾紛甯冩浛灏兼不鐤楀悗鐤楁晥涓嶄匠銆�<\/p> \n
闅忔満鐨勯槦鍒�1鍦ㄦ辰甯冩浛灏艰瘯楠岃噦涓叆缁勪簡102渚嬫偅鑰咃紝鍏朵腑83渚嬩负澶嶅彂鎴栭毦娌绘€э紙R\/R锛夋偅鑰呫€�19渚嬩负鍒濇不锛圱N锛夋偅鑰咃紱鍦ㄤ紛甯冩浛灏艰瘯楠岃噦涓叆缁勪簡99渚嬫偅鑰咃紝鍏朵腑81渚嬩负R\/R鎮h€呫€�18渚嬩负TN鎮h€呫€傚叆缁勬辰甯冩浛灏艰瘯楠岃噦鐨勬偅鑰呮帴鍙椾簡鍓傞噺涓烘瘡娆�160姣厠銆佹瘡鏃ヤ袱娆★紙BID锛夌殑娉藉竷鏇垮凹娌荤枟锛涘叆缁勪紛甯冩浛灏艰瘯楠岃噦鐨勬偅鑰呮帴鍙椾簡鍓傞噺涓烘瘡娆�420姣厠銆佹瘡鏃ヤ竴娆★紙QD锛夌殑浼婂竷鏇垮凹娌荤枟銆�<\/p> \n
闃熷垪2鐨勭粨鏋滀簬鍏堝墠鍦ㄧ24灞婃娲茶娑插鍗忎細锛圗HA锛夊勾浼氫笂琚叕甯冿紝鍏朵腑灞曠ず浜�80.8%鐨勬€荤紦瑙g巼锛圤RR锛夛紝涓昏缂撹В锛圡RR锛涘寘鎷揪鍒伴儴鍒嗙紦瑙f垨鏇村ソ锛夌巼涓�53.8%锛孷GPR 鐜囦负23.1%銆� <\/p> \n
鍏充簬鐧炬偊娉�<\/b>®<\/sup><\/b>锛堟辰甯冩浛灏硷級<\/b> <\/b><\/p> \n
鐧炬偊娉�®<\/sup>锛堟辰甯冩浛灏硷級鏄竴娆剧敱鐧炬祹绁炲窞绉戝瀹惰嚜涓荤爺鍙戠殑甯冮瞾椤挎皬閰皑閰告縺閰讹紙BTK锛夊皬鍒嗗瓙鎶戝埗鍓傦紝鐩墠姝e湪鍏ㄧ悆杩涜骞挎硾鐨勫叧閿€т复搴婅瘯楠岄」鐩紝浣滀负鍗曡嵂鍜屼笌鍏朵粬鐤楁硶杩涜鑱斿悎鐢ㄨ嵂娌荤枟澶氱B缁嗚優鎭舵€ц偪鐦ゃ€� <\/p> \n
鐧炬偊娉�®<\/sup>宸插湪浠ヤ笅閫傚簲鐥囧拰鍦板尯涓幏鎵癸細<\/p> \n
鍦ㄥ姞鎷垮ぇ锛屼竴椤圭櫨鎮︽辰®<\/sup>浣滀负鏃㈠線鎺ュ彈杩囪嚦灏戜竴椤圭枟娉曠殑MCL鎮h€呯殑娌荤枟鏂规鐨勪笂甯傝鍙敵璇峰凡琚彈鐞嗗苟姝e湪鎺ュ彈瀹¤瘎銆傛澶栵紝鍙︽湁20椤圭櫨鎮︽辰®<\/sup>鐨勭浉鍏充笂甯傜敵璇峰凡鍦ㄥ叏鐞冨寘鎷編鍥姐€佷腑鍥藉拰娆х洘鍦ㄥ唴鐨�40涓浗瀹跺拰鍦板尯瀹屾垚閫掍氦宸ヤ綔銆�<\/p> \n
*璇ラ」閫傚簲鐥囧熀浜庢€荤紦瑙g巼锛圤RR锛夎幏寰楀姞閫熸壒鍑嗐€傞拡瀵硅閫傚簲鐥囩殑鎸佺画鎵瑰噯灏嗗彇鍐充簬楠岃瘉鎬ц瘯楠屼腑涓村簥鐩婂鐨勯獙璇佸拰鎻忚堪銆�<\/p> \n
**璇ラ」閫傚簲鐥囪幏闄勬潯浠舵壒鍑嗐€傞拡瀵硅閫傚簲鐥囩殑瀹屽叏鑾锋壒灏嗗彇鍐充簬涓€椤规垨澶氶」姝e湪杩涜鐨勯殢鏈恒€佸鐓ч獙璇佹€т复搴婅瘯楠岀粨鏋溿€�<\/p> \n
鍏充簬鐧炬祹绁炲窞<\/b><\/p> \n
鐧炬祹绁炲窞鏄竴瀹跺叏鐞冩€с€佸晢涓氶樁娈电殑鐢熺墿绉戞妧鍏徃锛屼笓娉ㄤ簬鐮旂┒銆佸紑鍙戙€佺敓浜т互鍙婂晢涓氬寲鍒涙柊鎬ц嵂鐗╀互涓哄叏涓栫晫鎮h€呮彁楂樼枟鏁堝拰鑽搧鍙強鎬с€傜櫨娴庣宸炵洰鍓嶅湪鍏ㄧ悆鎷ユ湁5400 澶氬悕鍛樺伐锛屾鍦ㄥ姞閫熸帹鍔ㄥ叕鍙稿鍏冨寲鐨勬柊鍨嬬檶鐥囩枟娉曡嵂鐗╃绾裤€傜洰鍓嶏紝鐧炬祹绁炲窞涓ゆ鑷富鐮斿彂鐨勮嵂鐗╋紝BTK 鎶戝埗鍓傜櫨鎮︽辰®<\/sup>锛堟辰甯冩浛灏艰兌鍥婏級姝e湪缇庡浗鍜屼腑鍥借繘琛岄攢鍞€佹姉PD-1鎶椾綋鑽墿鐧炬辰瀹�®<\/sup>锛堟浛闆峰埄鐝犲崟鎶楁敞灏勬恫锛夊湪涓浗杩涜閿€鍞€傛澶栵紝鐧炬祹绁炲窞鍦ㄤ腑鍥芥鍦ㄦ垨璁″垝閿€鍞娆剧敱瀹夎繘鍏徃銆佹柊鍩虹墿娴佹湁闄愬叕鍙革紙闅跺睘鐧炬椂缇庢柦璐靛疂鍏徃锛変互鍙奅USA Pharma鎺堟潈鐨勮偪鐦よ嵂鐗╋紝骞朵笌璇哄崕杈炬垚鍚堜綔浠ュ湪鍖楃編銆佹娲插拰鏃ユ湰寮€鍙戝拰鍟嗕笟鍖栨姉PD-1鎶椾綋鐧炬辰瀹�®<\/sup>銆傛浜嗚В鏇村淇℃伅锛岃璁块棶www.beigene.com.cn<\/a>銆�<\/p> \n
<\/p> \n
\n
[i] BRUKINSA (zanubrutinib) Canadian Product Monograph. March 2021<\/span>. 鐧炬偊娉�®<\/sup>鍔犳嬁澶ц嵂鍝佷笓璁猴紙2021骞�3鏈堬級<\/p> \n
[ii] Lymphoma Research Foundation. Available at https:\/\/lymphoma.org\/aboutlymphoma\/nhl\/wm\/<\/a>. Accessed December 2020<\/span>.<\/p> \n
[iii] Waldenstrom鈥檚 Macroglobulinemia Foundation of Canada<\/span>. https:\/\/wmfc.ca\/what-we-do\/what-is-wm\/<\/a>.<\/p>"]; $("#dvExtra").html(content_array[0]);})();